[HTML][HTML] Blood GFAP as an emerging biomarker in brain and spinal cord disorders

A Abdelhak, M Foschi, S Abu-Rumeileh… - Nature Reviews …, 2022 - nature.com
Blood-derived biomarkers for brain and spinal cord diseases are urgently needed. The
introduction of highly sensitive immunoassays led to a rapid increase in the number of …

Blood biomarkers for detection of brain injury in COVID-19 patients

ST DeKosky, PM Kochanek, AB Valadka… - Journal of …, 2021 - liebertpub.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus attacks multiple
organs of coronavirus disease 2019 (COVID-19) patients, including the brain. There are …

Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum

AL Benedet, M Milà-Alomà, A Vrillon, NJ Ashton… - JAMA …, 2021 - jamanetwork.com
Importance Glial fibrillary acidic protein (GFAP) is a marker of reactive astrogliosis that
increases in the cerebrospinal fluid (CSF) and blood of individuals with Alzheimer disease …

Glial fibrillary acidic protein serum levels distinguish between intracerebral hemorrhage and cerebral ischemia in the early phase of stroke

S Luger, J Witsch, A Dietz, GF Hamann… - Clinical …, 2017 - academic.oup.com
BACKGROUND Recent studies have suggested that glial fibrillary acidic protein (GFAP)
serum concentrations distinguish between intracerebral hemorrhage (ICH) and ischemic …

[HTML][HTML] Serum GFAP and UCH-L1 for the prediction of neurological outcome in comatose cardiac arrest patients

F Ebner, M Moseby-Knappe, N Mattsson-Carlgren… - Resuscitation, 2020 - Elsevier
Objective Neurological outcome prediction is crucial early after cardiac arrest. Serum
biomarkers released from brain cells after hypoxic-ischaemic injury may aid in outcome …

Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma

J Tichy, S Spechtmeyer, M Mittelbronn… - Journal of neuro …, 2016 - Springer
Glioblastoma (GBM) is the most common malignant primary brain tumor. Although clinical
presentation and brain imaging might be suggestive, histopathological evaluation by means …

[HTML][HTML] Novel serum biomarkers for predicting neurological outcomes in postcardiac arrest patients treated with targeted temperature management

H Song, HJ Bang, Y You, JS Park, C Kang, HJ Kim… - Critical Care, 2023 - Springer
Objective To determine the clinical feasibility of novel serum biomarkers in out-of-hospital
cardiac arrest (OHCA) patients treated with target temperature management (TTM). Methods …

Biomarkers of cerebral injury for prediction of postoperative cognitive dysfunction in patients undergoing cardiac surgery

S Wiberg, F Holmgaard, H Zetterberg… - … of Cardiothoracic and …, 2022 - Elsevier
Objectives To assess the ability of the biomarkers neuron-specific enolase (NSE), tau,
neurofilament light chain (NFL), and glial fibrillary acidic protein (GFAP) to predict …

[HTML][HTML] Protein S100 as outcome predictor after out-of-hospital cardiac arrest and targeted temperature management at 33 C and 36 C

P Stammet, J Dankiewicz, N Nielsen, F Fays… - Critical Care, 2017 - Springer
Background We aimed to investigate the diagnostic performance of S100 as an outcome
predictor after out-of-hospital cardiac arrest (OHCA) and the potential influence of two target …

[HTML][HTML] Brain injury biomarkers for predicting outcome after cardiac arrest

J Humaloja, NJ Ashton, MB Skrifvars - Critical Care, 2022 - Springer
This article is one of ten reviews selected from the Annual Update in Intensive Care and
Emergency Medicine 2022. Other selected articles can be found online at https://www …